These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

193 related articles for article (PubMed ID: 23121989)

  • 61. The prevalence of sexual dysfunction among male patients on methadone and buprenorphine treatments: a meta-analysis study.
    Yee A; Loh HS; Hisham Hashim HM; Ng CG
    J Sex Med; 2014 Jan; 11(1):22-32. PubMed ID: 24344738
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Opioid substitution treatment in pretrial prison detention: a case study from Geneva, Switzerland.
    Favrod-Coune T; Baroudi M; Casillas A; Rieder JP; Gétaz L; Barro J; Gaspoz JM; Broers B; Wolff H
    Swiss Med Wkly; 2013; 143():w13898. PubMed ID: 24186493
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Illicit use of opioid substitution drugs: prevalence, user characteristics, and the association with non-fatal overdoses.
    Bretteville-Jensen AL; Lillehagen M; Gjersing L; Andreas JB
    Drug Alcohol Depend; 2015 Feb; 147():89-96. PubMed ID: 25543167
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Methadone and buprenorphine for opioid dependence during pregnancy: a retrospective cohort study.
    Meyer MC; Johnston AM; Crocker AM; Heil SH
    J Addict Med; 2015; 9(2):81-6. PubMed ID: 25622120
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Can patients receiving opioid maintenance therapy safely drive? A systematic review of epidemiological and experimental studies on driving ability with a focus on concomitant methadone or buprenorphine administration.
    Strand MC; Fjeld B; Arnestad M; Mørland J
    Traffic Inj Prev; 2013; 14(1):26-38. PubMed ID: 23259516
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Opioid agonist doses for oxycodone and morphine dependence: Findings from a retrospective case series.
    Nielsen S; Bruno R; Degenhardt L; Demirkol A; Lintzeris N
    Drug Alcohol Rev; 2017 May; 36(3):311-316. PubMed ID: 27273511
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Methadone, buprenorphine and preferences for opioid agonist treatment: A qualitative analysis.
    Yarborough BJ; Stumbo SP; McCarty D; Mertens J; Weisner C; Green CA
    Drug Alcohol Depend; 2016 Mar; 160():112-8. PubMed ID: 26796596
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Concomitant Heroin and Cocaine Use among Opioid-Dependent Patients during Methadone, Buprenorphine or Morphine Opioid Agonist Therapy.
    Gastberger S; Baumgartner MR; Soyka M; Quednow BB; Hulka LM; Herdener M; Seifritz E; Mutschler J
    Eur Addict Res; 2019; 25(4):207-212. PubMed ID: 31067528
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Diversion of opioid maintenance treatment medications and predictors for diversion among Finnish maintenance treatment patients.
    Launonen E; Alho H; Kotovirta E; Wallace I; Simojoki K
    Int J Drug Policy; 2015 Sep; 26(9):875-82. PubMed ID: 25934054
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Opioid-related mortality and filled prescriptions for buprenorphine and methadone.
    Wikner BN; Öhman I; Seldén T; Druid H; Brandt L; Kieler H
    Drug Alcohol Rev; 2014 Sep; 33(5):491-8. PubMed ID: 24735085
    [TBL] [Abstract][Full Text] [Related]  

  • 71. The OPTIMA study, buprenorphine/naloxone and methadone models of care for the treatment of prescription opioid use disorder: Study design and rationale.
    Socias ME; Ahamad K; Le Foll B; Lim R; Bruneau J; Fischer B; Wild TC; Wood E; Jutras-Aswad D
    Contemp Clin Trials; 2018 Jun; 69():21-27. PubMed ID: 29627621
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Perceptions of extended-release naltrexone, methadone, and buprenorphine treatments following release from jail.
    Velasquez M; Flannery M; Badolato R; Vittitow A; McDonald RD; Tofighi B; Garment AR; Giftos J; Lee JD
    Addict Sci Clin Pract; 2019 Oct; 14(1):37. PubMed ID: 31570100
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Effects of medication assisted treatment (MAT) for opioid use disorder on functional outcomes: A systematic review.
    Maglione MA; Raaen L; Chen C; Azhar G; Shahidinia N; Shen M; Maksabedian E; Shanman RM; Newberry S; Hempel S
    J Subst Abuse Treat; 2018 Jun; 89():28-51. PubMed ID: 29706172
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Randomized clinical trial comparing buprenorphine/naloxone and methadone for the treatment of patients with failed back surgery syndrome and opioid addiction.
    Neumann AM; Blondell RD; Hoopsick RA; Homish GG
    J Addict Dis; 2020; 38(1):33-41. PubMed ID: 31774028
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Acute Pain Management for Patients Receiving Medication-Assisted Therapy.
    Compton P
    AACN Adv Crit Care; 2019 Dec; 30(4):335-342. PubMed ID: 31951656
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Influence of peak and trough levels of opioid maintenance therapy on driving aptitude.
    Baewert A; Gombas W; Schindler SD; Peternell-Moelzer A; Eder H; Jagsch R; Fischer G
    Eur Addict Res; 2007; 13(3):127-35. PubMed ID: 17570908
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Fatal and non-fatal opioid overdose in opioid dependent patients treated with methadone, buprenorphine or implant naltrexone.
    Kelty E; Hulse G
    Int J Drug Policy; 2017 Aug; 46():54-60. PubMed ID: 28609749
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Diminished brain functional magnetic resonance imaging activation in patients on opiate maintenance despite normal spatial working memory task performance.
    Bach P; Vollstädt-Klein S; Frischknecht U; Hoerst M; Kiefer F; Mann K; Ende G; Hermann D
    Clin Neuropharmacol; 2012; 35(4):153-60. PubMed ID: 22805228
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Characterization of diverted buprenorphine use among adults entering corrections-based drug treatment in Kentucky.
    Smith KE; Tillson MD; Staton M; Winston EM
    Drug Alcohol Depend; 2020 Mar; 208():107837. PubMed ID: 31951906
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Buprenorphine implants in medical treatment of opioid addiction.
    Chavoustie S; Frost M; Snyder O; Owen J; Darwish M; Dammerman R; Sanjurjo V
    Expert Rev Clin Pharmacol; 2017 Aug; 10(8):799-807. PubMed ID: 28571505
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.